AngioDynamics
ANGO
132 hedge funds and large institutions have $454M invested in AngioDynamics in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 15 closing their positions.
246% more call options, than puts
Call options by funds: $1.4M | Put options by funds: $403K
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
2% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 47
0% more funds holding
Funds holding: 132 → 132 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
60% less capital invested
Capital invested by funds: $1.14B → $454M (-$691M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
+$17M |
| 2 |
KI
Kalmar Investments
Greenville,
Delaware
|
+$8.92M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$6.76M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$4.16M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$669M |
| 2 |
PGH
Partners Group Holding
Baar-Zug,
Switzerland
|
-$11.7M |
| 3 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$5.77M |
| 4 |
BC
Broadfin Capital
New York
|
-$5.06M |
| 5 |
RA
Royce & Associates
New York
|
-$3.31M |
ANGO Hedge Fund Activity: Q1 2015 in Review
132 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2015, worth a combined $454M — down 60% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ANGO positions and 15 closed out — a net gain of 1 holder — while 48 added to existing stakes and 47 trimmed.
The largest buyer was Fiduciary Management Associates, opening a new position worth an estimated $17M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $669M sold.
- 132 institutional investors held AngioDynamics (ANGO) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $454M of AngioDynamics stock for Q1 2015, down 60% quarter-over-quarter.
- 16 funds opened new AngioDynamics positions in Q1 2015 and 15 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q1 2015 was Fiduciary Management Associates, an estimated $17M added.
- The largest AngioDynamics seller in Q1 2015 was Americafirst Capital Management, an estimated $669M sold.
Based on aggregated 13F filings for Q1 2015.